Raef Fadel

Chief Resident

Henry Ford Hospital

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Raef Fadel is the Chief Resident at Henry Ford Hospital in the United States. His research primarily focuses on the clinical aspects and outcomes of COVID-19, including the impact of sociodemographic factors, treatment effectiveness, and patient characteristics. Recent publications highlight his work on mortality predictors in COVID-19 patients, the implementation of hypertension guidelines, and the implications of liver injury in severe cases.

Articles (10)

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (1)

Tuan-Minh Nguyen

Wright State University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Raef Fadel

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

The Impact of Sociodemographic Factors, Comorbidities, and Physiologic Responses on 30-Day Mortality in Coronavirus Disease 2019 (COVID-19) Patients in Metropolitan Detroit.

Visual Analytics Dashboard Promises to Improve Hypertension Guideline Implementation.

Mechanical Ventilation and Coronavirus Disease 2019: A Case-Control Analysis of Clinical Characteristics, Lung Mechanics, and Mortality.

COVID-19: disease pathways and gene expression changes predict methylprednisolone can improve outcome in severe cases.

Racial Differences in a Detroit, MI, ICU Population of Coronavirus Disease 2019 Patients.

Early Short-Course Corticosteroids in Hospitalized Patients With COVID-19.

Liver Injury as a Surrogate for Inflammation and Predictor of Outcomes in COVID-19.

Clinical characteristics and outcomes of COVID-19 in solid organ transplant recipients: A cohort study.

Impact of COVID-19 Infection on 24 Patients with Sickle Cell Disease. One Center Urban Experience, Detroit, MI, USA.

Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19.

Collaborators (1)

Tuan-Minh Nguyen

Make your next move.